|1.||Chen, Hui: 12 articles (10/2015 - 12/2010)|
|2.||Lin, Sheng-Zhang: 11 articles (10/2015 - 01/2008)|
|3.||Yi, Jing: 9 articles (02/2013 - 01/2004)|
|4.||Wang, Zhao-Hong: 8 articles (10/2015 - 11/2011)|
|5.||Liu, An: 8 articles (05/2012 - 02/2011)|
|6.||Chung, Jing-Gung: 8 articles (05/2012 - 01/2006)|
|7.||Tong, Hong-Fei: 7 articles (10/2015 - 11/2011)|
|8.||Liu, Dian-Lei: 7 articles (06/2015 - 12/2011)|
|9.||Yang, Jie: 6 articles (01/2014 - 01/2004)|
|10.||Guo, Hong-Chun: 6 articles (12/2012 - 11/2011)|
12/01/2014 - "In studies of the cytotoxicity, the complex exhibited significant activity, and the IC50 values of the complex against five cancer cell lines improved approximately three-fold compared with those of emodin. "
06/01/2013 - "The result shows that large conjugative system can not enhance the anticancer activities of emodin derivatives, but the introduction of an alkylating center can make emodin derivative effective against cancer cell lines. "
06/01/2012 - "Emodin has therapeutic potential against cancers. "
01/01/2015 - "In addition, many studies have shown that emodin and emodin derivatives are able to inhibit growth of ErbB2-overexpressing tumor cells. "
11/01/2013 - "The evolving concept of pro-oxidative mechanism-based antitumor activity of emodin (1,3,8-trihydroxy-6-methyl anthraquinone), derived mainly from in vitro studies, needs to be defined for in vivo tumor models. "
|2.||Breast Neoplasms (Breast Cancer)
09/19/2012 - "In this study, we investigated the effects of emodin on reversing the multi-drug resistance, examined the ERCC1 protein expression in breast cancer cell line, and explored the relationship between reversal of multi-drug resistance and ERCC1 protein expression. "
06/01/2008 - "In this study, we focused on the effect of emodin in human breast cancer BCap-37 cells and further understand the underlying molecular mechanism in treating breast cancer. "
05/01/1996 - "In this study, emodin effectively suppressed growth of MDA-MB-435, a breast cancer cell line with low HER-2/neu expression. "
07/01/2014 - "Emodin azide methyl anthraquinone derivative induced G0/ G1 arrest in HER2/neu-overexpressing MDA-MB-453 breast cancer cells."
07/01/2013 - "Finally, the in vivo invasiveness of the P2X7R-positive MDA-MB-435s breast cancer cells, assessed using a zebrafish model of micrometastases, was suppressed by 40 and 50% by 1 and 10 µM emodin. "
10/01/2013 - "This study aimed to investigate the protective effect of emodin on endoplasmic reticulum (ER) stress in rats with severe acute pancreatitis (SAP) and the underlying molecular mechanism. "
08/01/2002 - "Studies have revealed that emodin is a potent agent in the management of clinical and experimental acute pancreatitis, but the molecular mechanisms by which emodin produces its biologic effects, especially on pancreatic regeneration after acute pancreatitis, remain unknown. "
02/01/2015 - "Emodin has a protective effect in cases of severe acute pancreatitis via inhibition of nuclear factor‑κB activation resulting in antioxidation."
10/01/2013 - "Effect of emodin on endoplasmic reticulum stress in rats with severe acute pancreatitis."
01/09/2013 - "Emodin could be detected in all rats' pancreas at 48 h in both groups, while its mean pancreatic concentration was higher in acute pancreatitis model group than in normal group (0.91 ± 0.68, 0.41 ± 0.36, respectively). "
09/26/2006 - "To study the effect of emodin on pancreatic fibrosis and potential mechanism thereof. "
08/01/2001 - "To investigate the effect of emodin on hepatic fibrosis in rats and study its possible mechanism. "
08/01/2014 - "When active anti-fibrosis compound emodin was installed in HCA-Chi-Zn-emodin and intravenously injected to the ureter obstructed mice, obvious attenuation of fibrotic progression was exhibited. "
10/14/2009 - "Emodin might be a therapeutic antifibrotic agent for the treatment of hepatic fibrosis."
10/14/2009 - "The degree of hepatic fibrosis increased markedly in the CCl(4) group compared to the normal group (P < 0.01), and decreased markedly in the emodin group compared to the CCl(4) group according to METAVIR scale (P < 0.01) compared with those in the normal control group (51.02 +/- 10.64 IU/L and 132.28 +/- 18.14 IU/L). "
|5.||Schizophrenia (Dementia Praecox)
01/01/2008 - "The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia."
12/01/2010 - "Previously, we found that the anthraquinone derivative emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits ErbB1 signaling and ameliorates behavioral deficits of the schizophrenia animal model established by EGF challenge. "
|6.||Small Interfering RNA (siRNA)
|7.||Hyaluronic Acid (Hyaluronan)
|8.||Ethanol (Ethyl Alcohol)
|9.||Toll-Like Receptor 2
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)
|4.||Enteral Nutrition (Feeding, Tube)